SCHEMBL40769

SCHEMBL40769

Cc1ccc(C(=O)Cl)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
HTT P42858 1/20 0.55
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
ALDH1A1 P00352 4/20 0.48
NPC1 O15118 3/20 0.48
MITF O75030 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47
MAPT P10636 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 5/20 0.46
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30475402 1.00 SMN1; SMN2 (0.55) SMN1; SMN2CES2CES1HTTPRSS1
SCHEMBL1773780 0.84 CES2 (0.39) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL2154161 0.84 HSD17B1 (0.43) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL31634804 0.84 CES2 (0.39) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL1375362 0.82 HDAC8 (0.41) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL31590951 0.82 TDP1 (0.48) SMN1; SMN2HTTALDH1A1POLBMAPT
SCHEMBL4276908 0.82 TRPA1 (0.47) SMN1; SMN2HTTALDH1A1POLBMAPT
SCHEMBL4546533 0.82 HPGD (0.53) SMN1; SMN2ALDH1A1NPC1LMNAPOLB
SCHEMBL2972020 0.82 TAS1R3 (0.51) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL925050 0.80 HDAC1 (0.61) CES2CES1HTTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104693062-B Phenylacetylene derivatives and preparation of the side base with ester group, polymerization and methods for using them 哈尔滨工程大学 2017-10-03 CN claimed
CN-104910039-A Functional phenylacetylene compound and preparation method thereof UNIV HARBIN ENG 2015-09-16 CN claimed
CN-104693062-A Phenylacetylene derivative with ester group on lateral base band and preparation, polymerization and application methods UNIV HARBIN ENG 2015-06-10 CN claimed
EP-2288652-B1 PREPARATION FOR INITIATING RADICAL REACTIONS UNITED INITIATORS GMBH & CO KG (DE) 2012-09-19 EP claimed
US-20110272628-A1 Preparation For Initiating Radical Reactions UNITED INITIATORS GMBH (DE) 2011-11-10 US claimed
EP-2288652-A1 PREPARATION FOR INITIATING RADICAL REACTIONS United Initiators GmbH & Co. KG (DE) 2011-03-02 EP claimed
WO-2009146916-A1 PREPARATION FOR INITIATING RADICAL REACTIONS UNITED INITIATORS GMBH & CO. KG (DE) 2009-12-10 WO claimed
EP-2130858-A1 Preparations to initiate radical reactions Degussa Initiators GmbH & Co. KG (DE) 2009-12-09 EP claimed
US-5210313-A Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids MAXDEM INCORPORATED (US) 1993-05-11 US claimed
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-09 US disclosed
WO-2025098545-A1 NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) 2025-05-15 WO disclosed
EP-4553080-A1 NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) 2025-05-14 EP disclosed
EP-4536653-A2 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME Eisai R&D Management Co., Ltd. (JP) 2025-04-16 EP disclosed
CN-117924279-B MELK inhibitor and application thereof 中山大学 2024-07-16 CN disclosed
US-4187230-A Preparation of 5-aroyl-pyrrole compounds ETHYL CORPORATION (US) 1980-02-05 US disclosed
US-4176113-A ANTRAQUINONE DYES CIBA-GEIGY CORPORATION (US) 1979-11-27 US disclosed
US-4138581-A BRONCHODILATOR AGENTS, ADRENERGIC STIMULANTS STERLING DRUGS INC. (US) 1979-02-06 US disclosed
US-4004008-A ANTISPASMODIC, VASODILATION ROTTA RESEARCH LABORATORIUM S.P.A. (IT) 1977-01-18 US disclosed
US-4000307-A HYPOLIPIDEMIC SANDOZ, INC. (US) 1976-12-28 US disclosed
US-3952012-A MULTISTAGE MCNEIL LABORATORIES, INCORPORATED (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME NEU1, NEU2, NEU4 SMN1; SMN2 301/4885CES2 775/4885CES1 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.